Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 30, 2009
A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in SwedenUlf Persson, Michael Willis, Knut Odegaard
Journal of Medical Economics|May 31, 2013
Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM)Michael Willis, Christian Asseburg, Jianming He
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 26, 2019
Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature ReviewMichael Willis, Christian Asseburg, Andreas Nilsson, et al.
Pharmacoeconomics|November 14, 2016
Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)Michael Willis, Pierre Johansen, Andreas Nilsson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 3, 2011
Chromogranin peptides in brain diseasesMichael Willis, Irmgard Leitner, Kurt A Jellinger, et al.
Pharmacoeconomics|February 13, 2021
Macrovascular Risk Equations Based on the CANVAS ProgramMichael Willis, Christian Asseburg, April Slee, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 15, 2020
Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial DataMichael Willis, Christian Asseburg, April Slee, et al.
Pageof 6